Safety and efficacy of ANGIOGUARD protection device for the prevention of distal embolization during PCI in patients with unstable anginaInter-individual variability in response to clopidogrel in patients with coronary artery diseaseSafety and efficacy of dalteparin administration for elective percutaneous interventions in patients pre-treated with aspirin and ticlopidineRandomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesionsMore aggressive pharmacological treatment may improve clinical outcome in patients with non-ST-elevation acute coronary syndromes treated conservativelyEffects of high-dose statin administered prior to coronary angioplasty on the incidence of cardiac events in patients with acute coronary syndromeBivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trialBivalirudin during primary PCI in acute myocardial infarctionImpact of multiple complex plaques on short- and long-term clinical outcomes in patients presenting with ST-segment elevation myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIBorderline trend towards long-term mortality benefit from drug eluting stents implantation in ST-elevation myocardial infarction patients in Poland-data from NRDES registry.Twelve months clinical outcome after bioresorbable vascular scaffold implantation in patients with stable angina and acute coronary syndrome. Data from the Polish National Registry[Left ventricular systolic function in patients with refractory angina pectoris treated with percutaneous myocardial laser revascularisation, results of long-term follow-up].Decreased carotid and vertebral arterial blood-flow velocity in response to orthostatic unload in patients with severe aortic stenosis.Comparison of outcomes in patients with ST-segment elevation myocardial infarction discharged on versus not on statin therapy (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial).Assessment of the absorption process following bioabsorbable everolimus-eluting stent implantation: temporal changes in strain values and tissue composition using intravascular ultrasound radiofrequency data analysis. A substudy of the ABSORB clinicManagement and mortality in patients with non-ST-segment elevation vs. ST-segment elevation myocardial infarction. Data from the Malopolska Registry of Acute Coronary Syndromes.Individual patient-data meta-analysis comparing clinical outcome in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention with or without prior thrombectomy. ATTEMPT study: a pooled Analysis of Trials on ThEarly abciximab administration before primary percutaneous coronary intervention improves clinical outcome in elderly patients transferred with ST-elevation myocardial infarction: data from the EUROTRANSFER registry.Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials.Transradial approach in patients with ST-elevation myocardial infarction treated with abciximab results in fewer bleeding complications: data from EUROTRANSFER registry.Early abciximab use in ST-elevation myocardial infarction treated with primary percutaneous coronary intervention improves long-term outcome. Data from EUROTRANSFER Registry.Clinical Correlates and Prognostic Value of Plasma Galectin-3 Levels in Degenerative Aortic Stenosis: A Single-Center Prospective Study of Patients Referred for Invasive TreatmentAbciximab in the management of acute myocardial infarction with ST-segment elevation: evidence-based treatment, current clinical use, and future perspectivesOut-of-hospital cardiac arrest in patients treated with primary PCI for STEMI. Long-term follow up data from EUROTRANSFER registry.Impact of infarct related artery patency after early abciximab administration on one-year mortality in patients with ST-segment elevation myocardial infarction (data from the EUROTRANSFER Registry).Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months.A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomesRandomized clinical trial comparing percutaneous closure of patent foramen ovale (PFO) using the Amplatzer PFO Occluder with medical treatment in patients with cryptogenic embolism (PC-Trial): rationale and design.A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial.Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque.A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods.Coronary microcirculation and reperfusion failure. Do we know what diagnostic tools we have?Complete infarct-related artery revascularization in acute myocardial infarction patients. CORAMI RegistryTransradial percutaneous coronary intervention for unprotected left main closure during acute myocardial infarction.Age-related differences in treatment strategies and clinical outcomes in unselected cohort of patients with ST-segment elevation myocardial infarction transferred for primary angioplastyPercutaneous interventions in cardiology in Poland in the year 2014. Summary report of the Association of Cardiovascular Interventions of the Polish Cardiac Society AISN PTK.Impact of smoking status on outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary interventionHistopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortiumPredictors of coronary and carotid atherosclerosis in patients with severe degenerative aortic stenosisEarly administration of abciximab reduces mortality in female patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the EUROTRANSFER Registry).
P50
Q28167329-7256D5D0-0FAA-4268-A5F1-A87D2DA9FDE1Q28173909-EFB41EE5-3C4B-4D63-8719-A7769165292FQ28174271-477D0EE5-2614-49C1-97D4-591799835C4EQ28191771-F165EFFA-394A-4DB6-89F7-8F14F6838EADQ28210384-E2FDAEDD-6697-4BAB-86F5-B0C51ACC7067Q28213880-DA49F260-6DC8-4378-B781-21251CB4114BQ28256871-2D677CDF-DDCF-4BB6-BC3D-638845C89538Q28281179-A06FF32E-0E43-419F-878E-48D954B0F70BQ30398247-EC388398-6992-4E8C-90B0-FE1747876BECQ30667055-77802F63-2C41-4A96-B8EC-E3EEB49D06A4Q31106727-A6F64C40-E21A-421C-8CAD-F1EB7AE166CDQ31148961-0B7E4CDD-54ED-4FD3-8490-C38206393B38Q33167364-B91EB2A5-775E-443F-BDE9-9B6D0414E71FQ33413571-356A8B3F-DA74-49D1-A135-600CEE8C0C47Q33417789-365A44FF-74A7-4992-A295-F5A7432AA66BQ33418449-C2B17575-97AA-4DAF-9517-6C9EAFC2D30DQ33444609-958AD868-1A20-4989-9CA1-B6DDBFDCCE8FQ33475333-B1329586-4B08-405F-B8D4-255850A93D32Q33499610-C92A4AF0-B65E-45EC-BEF7-347C518F6DBDQ33572740-FEA65DA6-4221-4399-86EF-940BDF4DA345Q33583859-51C5FB58-CDBC-46CA-8050-BD8645549F48Q33754895-B256424C-A55D-497A-BED1-421D66188F15Q33952693-7F3C6015-627C-4F32-9E69-7E730AEC94B6Q34035278-0C07D41A-8205-4FD9-984E-0B615DD45C16Q34202315-5DB65C0C-6906-4E7A-8DA3-B786FDFF3FB2Q34388921-67177096-E103-4F33-9AB1-91198807D709Q34439201-5C300410-885A-4B34-AE78-4E3429617C25Q34677318-A35AAB47-20D4-4488-BF9A-2F81CD3D78F7Q34761876-55E435B9-105C-43C3-9228-659F602EE1E2Q34819606-05FD37CF-48AA-4BBF-8AC7-D5B04AAC679BQ34962488-A45BF009-F5C9-482A-9B14-E739D620E498Q35115144-EF0A9282-B51C-4CF4-A99F-F860A309D23AQ35829145-5661EC18-F90C-46C7-AB6F-5D7227D7AF4FQ35829176-778627E7-D2B7-4CF5-B6EE-222E970EC760Q36095614-9BE943EE-885D-4A81-953D-8A581C5ABF34Q36245028-1688CA98-28F1-435E-88B3-6E420BDB02FEQ36281977-81AAD721-A294-4B2D-9CF8-C2DCB96B774BQ36915078-2452D055-8E2E-4EFF-A968-E36481F4D887Q37119328-8B696E58-4B0F-4142-B513-A2E0528062E9Q37187636-3AFE0566-37BA-4E95-89DD-BCB107825689
P50
description
Polish internist and cardiologist
@en
cardioloog
@nl
polski lekarz, internista, kardiolog
@pl
name
Dariusz Dudek
@ast
Dariusz Dudek
@ca
Dariusz Dudek
@cs
Dariusz Dudek
@en
Dariusz Dudek
@es
Dariusz Dudek
@ga
Dariusz Dudek
@gl
Dariusz Dudek
@hr
Dariusz Dudek
@hsb
Dariusz Dudek
@it
type
label
Dariusz Dudek
@ast
Dariusz Dudek
@ca
Dariusz Dudek
@cs
Dariusz Dudek
@en
Dariusz Dudek
@es
Dariusz Dudek
@ga
Dariusz Dudek
@gl
Dariusz Dudek
@hr
Dariusz Dudek
@hsb
Dariusz Dudek
@it
altLabel
Dariusz Zbigniew Dudek
@pl
prefLabel
Dariusz Dudek
@ast
Dariusz Dudek
@ca
Dariusz Dudek
@cs
Dariusz Dudek
@en
Dariusz Dudek
@es
Dariusz Dudek
@ga
Dariusz Dudek
@gl
Dariusz Dudek
@hr
Dariusz Dudek
@hsb
Dariusz Dudek
@it
P214
P106
P1412
P1559
Dariusz Dudek
@pl
P19
P21
P213
0000 0001 1230 7964
P214
P27
P31
P3124
P569
1969-06-26T00:00:00Z
P691
P7293
9810575218505606
P734
P7859
viaf-163596693